Definium Therapeutics updates DT120 clinical trials and commercial plans
Go back to Definium Therapeutics updates DT120 clinical trials and commercial plans| (NASDAQ: DFTX) | Delayed: 44.33 +0.14 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.19 | 52 Week High | $ | |||
| Open | $43.76 | 52 Week Low | $ | |||
| Day High | $44.75 | P/E | N/A | |||
| Day Low | $43.26 | EPS | $ | |||
| Volume | 2,074,713 | |||||

